6th Neuropsychiatric Drug Development Summit
2023-10-10 - 2023-10-12 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The Definitive Industry Forum for Spearheading Non-Psychedelic & Psychedelic R&D
2023 is booming with novel psychiatric R&D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum, with notable approvals on the horizon, as unmet needs in PTSD, bipolar, anxiety, schizophrenia, depression, and ADHD become greater and greater. There is, therefore, a huge deal of novel and promising research to be discussed this October at the 6th Neuropsychiatric Drug Development Summit.
With discovery, preclinical, translational, and clinical scientists from the likes of Biogen, Otsuka, AbbVie, Genentech, Lundbeck, Delix Therapeutics, Atai, Gilgamesh, and Cerevel Therapeutics, don’t miss the field’s favorite conference, specifically dedicated to biopharma’s most pressing challenges of de-risking the translational gap and advancing transformative neuropsychiatric candidates through the clinic.
To know more visit: https://ter.li/sar413

14th World ADC San Diego 2023
2023-10-16 - 2023-10-19 | Sheraton San Diego Hotel and Marina, 1380 Harbor Island Dr, San Diego, CA, 92101, United States
The ADC renaissance shows no sign of slowing down with the ground-breaking approval of ELAHERE for platinum resistant ovarian cancer, Pfizer’s jaw-dropping acquisition of Seagen for $43 billion, and BMS’ $1 billion+ pact with Tubulis. There has been no better time to reunite the World ADC community and invest in progressing ADCs to front line treatments for patients.
The highly anticipated 14th World ADC San Diego (October 16-19, 2023 | San Diego, CA) returns as the world’s largest industry-dedicated discussion and networking forum addressing and overcoming the challenges in end-to-end ADC development.
Gain exclusive access to the full event guide to view the full agenda with 120+ industry-leading speakers.
Whether you’re new to the field or an ADC guru, there is something for everyone included in this year’s agenda. Some of your must-attend talks per track include:

Discovery Chemistry: Join Christopher Marvin, Principal Research Scientist, AbbVie as he reviews the design and optimization of glucocorticoid receptor modulator payloads for Immunology ADCs
Cellular Biology: Discuss with Robert Lawrence, Principal Scientist, Seagen the influence of artificial intelligence on ADC target discovery
Translational: Review a best-in-class translational study with Meijuan Li, Vice President, Head of Translational Sciences & Biostatistics, Eisai Oncology
Clinical Lessons: Be the first to hear industry-changing clinical results from ImmunoGen, Byondis, Iksuda Therapeutics, Seagen, Bliss Bio, Genentech and Elucidia Oncology
Process and Analytical Development: Debate the key considerations for ADC comparability studies in a dedicated roundtable lead by ADC CMC expert, Julie Beaudet, CMC Staff Scientist, Regeneron Pharmaceuticals
Manufacturing and Supply Chain: Explore the manufacturing of novel dolaLock ADCs with supply chain architecture with Engin Ayturk, Executive Director, CMC Process Development, Mersana Therapeutics

Access to the complete agenda here including a 7-tracked seminar day and 10 industry-beating workshops.
Don’t miss out on the chance to reunite with the antibody-drug conjugate community while reflecting on the exciting year that ADCs have had, and building momentum for the future of this innovative field.

2nd Operationalise: Early Access Programmes Europe Summit
2023-10-16 - 2023-10-18 | Hilton Canary Wharf, South Quay, Marsh Wall, London, E14 9SH, United Kingdom
The Early Access Programmes Summit Europe returns for a second year this October, aiming to help the industry navigate the notoriously complex European regulatory landscape, and conquer operational hurdles to provide patients in Europe with early access to medicines.

This meeting provides a forum to address burning questions and share ideas on topics such as European regulatory guidelines, labelling, supply, and best practices around reimbursement, integrating of pre- and post-trial access programmes and scoping.
Providing practical, valuable case studies is this year’s expert speaker lineup including the likes of GlaxoSmithKline, Roche, Novartis, Sanofi, and many others! Visit our website to download a free copy of the full event guide to explore the jam-packed 3-day agenda and full speaker faculty.
Whether you’re a veteran at managing early access programmes and are looking to expand your geo, or a new entrant to the field, you’ll leave this conference with the practical lessons and essential connections needed to supercharge your European early access programme across 2023 and beyond.
To know more visit: https://bit.ly/3K4BpqO

4th Commercializing Flow Chemistry Summit
2023-10-16 - 2023-10-18 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Scaling Flow Chemistry for Sustainability, Safety and Speed to Market
With the growing demand for better flow technology, the 4th Commercializing Flow Chemistry Summit is your must-attend meeting to deep-dive into transforming your process efficiency, emerging technology toolbox and economic gains through strategic flow chemistry.
With unmissable case studies from the likes of Novartis, Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Takeda, this is the definitive forum to benchmark and learn with this forward-thinking community who reunite once more.
These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

Elevate Sustainability with Industry Leaders: Join forces with Merck, Eli Lilly and AbbVie to integrate sustainable practices seamlessly into your workflow, enhancing both environmental responsibility and operational excellence
Unlock Efficiency through Automation: Discover the power of automation in flow chemistry, following the footsteps of efficiency leaders like Sanofi, Takeda, and Boehringer Ingelheim, and optimize your processes for peak performance
Master Multi-Step Techniques: Gain expert insights from Boehringer Ingelheim on handling multi-step reactions in both flow and batch setups, fine-tuning your manufacturing processes for maximum efficiency and output

Don’t miss this opportunity to streamline your continuous chemistry research into scaled commercial applications, and together with 80+ process chemists, engineers, and modellers, go beyond reaction to work up optimization to develop winning processes quicker and expedite your drug development.
To know more visit: https://ter.li/jfxs1m

2nd Innate Killer Summit Europe 2023
2023-10-17 - 2023-10-19 | Crowne Plaza London, Royal Victoria Dock, Western Gateway, London, E16 1AL, United Kingdom
The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-shelf, solid tumour immunotherapies through effective and scalable engineering, engager and combination strategies that promote safe, potent and persistent innate immune therapies following application.
Don’t miss this chance to network with innate immune trailblazers from the likes of Sanofi, Takeda, Lift Biosciences, Mink Therapeutics, Affimed, Carisma Therapeutics, Arovella Therapeutics and receive 3-days of some of the best scientific and data driven case studies that will help propel your innate immune therapy into the clinic and beyond. Learn more – https://ter.li/nkcwg3

11th IMPACCT: Real World Evidence Summit 2023
2023-10-23 - 2023-10-25 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Returning for its 11th year, the IMPACCT: Real World Evidence Summit 2023 will deep dive into the use of RWE for regulatory submissions and clinical trial innovation to unlock unstructured healthcare data and transform disease treatment.
Join 100+ senior leaders in RWE, RWD, real world analytics & epidemiologists from pharma and biotech to take part in this three-day summit with over 18 hours of exclusive content.
Don’t miss your unique opportunity to explore how to leverage RWE to target patient populations and drive DE&I into trials. For more information go to: https://ter.li/db1xte

Biosensors for Medical Wearables Conference and Expo
2023-10-23 - 2023-10-24 | COURTYARD BY MARRIOTT BOSTON DOWNTOWN, 275 Tremont St, Boston, MA, 02116, United States
Biosensors for Medical Wearables Conference and Expo
*In collaboration with Medical Design Briefs*
October 23-24, 2023 | Boston, MA, USA
http://www.biosensors-medical-wear.com/PharmaJournalist-WL
SAE Media Group’s 3rd Annual Biosensors for Medical Wearables Conference will be back for 2023 in Boston to bring together device developers, MedTech, component manufacturers and big pharma to share and discuss the exciting advances in the medical wearable technology landscape.
The wearable biosensors market has grown significantly in recent years leading to increasingly growing potential for medical applications and at home alternatives for patients. With growing applications and potential in remote patient monitoring, diagnosis, therapeutics and detection of disease, wearable sensors are attracting considerable interest due to their opportunities in better supporting patients, clinical outcomes and decisions. Furthermore, AI and connected technologies are furthering the potential opportunities of this industry. However, challenges including flexibility of wearable devices, the collection of clinical-grade data and advanced battery technologies still remain for the industry to overcome. This year’s conference looks to address these hot topics through case studies and industry insights.
This is a must attend event, giving you the chance to engage in the latest innovations that are accelerating the wearable biosensors industry. We hope to welcome you in October 2023!
Reasons to attend:

Benchmark against and explore the latest biosensor technologies for wearable medical devices from Abbott, Empatica and Hexoskin
Delve into the potential of wearable sensors and digital tools in decentralized diagnosis including a Johnson & Johnson case study on the Heartline project
Learn how game changing companies such as Philips and Medtronic are utilizing wearables to maximize remote patient monitoring opportunities for wider patient populations
Explore how AI and machine learning technologies are enabling optimized data collection and streamlined data analysis
Discover cutting-edge biosensor therapeutic applications for neurology with Neurasantys and a panel discussion on future medical opportunities

Who you can meet?

Andreas Caduff, Strategic Advisory Board, DiME
Lorelie Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (an Abbott Company)
Tim Callahan, VP Scientific Affairs, Philips
Kara Chappie, Director and Project Lead, Pfizer
Jason Case, Vice President, Research and Development, Patient Monitoring, Medtronic
James Mault, MD, Founder and CEO, BioIntellisense, Inc.
Jasmin Imsirovic, Associate Director, Takeda
Janet Nikolovski, New Venture Lead – Genitourinary Oncology, Johnson & Johnson

CRISPR-Based Therapy Analytical Development Summit
2023-10-30 - 2023-11-01 | Hilton Boston Bay Back, 40 Dalton St, Boston, MA, 02115, United States
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex CRISPR structures necessitate cutting-edge advancements in analytical methods and tools to effectively characterize the genome-edited products utilizing CRISPR technology.
As industry experts tread unchartered territory, the inaugural CRISPR-Based Therapy Analytical Development Summit has been convened, gathering more than 60 distinguished experts in analytical development devoted to the creation, refinements and implementation of more robust analytical tools specifically tailored to CRISPR-based constructs.
Within this intimate space, we will adopt a shared consensus and delve into a comprehensive array of analytical techniques central to any CRISPR-based toolkit. Topics of discussion will span pioneering technology that includes everything from novel methods to characterize the guide RNA and whole CRISPR complex, to the use of next-generation sequencing (NGS) to detect and assess off-targets for superior safety evaluations.
In response to the regulatory bodies’ insistence on high-quality data to substantiate the safety and efficacy of genome-edited products, this summit is imperative to all individual engaged in the development of analytical tools and methodologies utilizing CRISPR technology as we build for better guidance around CRISPR-edited products.
If your role centers around analytical expertise and gene edited specialization, this meeting will enable you to streamline your analytical development process and connect in a shared goal to deliver safer therapies, with superior therapeutic benefit to patients faster.
To know more visit: https://ter.li/28jg6x

5th Gene Therapy for Neurological Disorders Summit
2023-11-06 - 2023-11-09 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
Accelerating More Transformative Gene Therapies for CNS Disorders
Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene therapies can act as transformative medicines within the CNS community.
The 5th Gene Therapy for Neurological Disorders Summit is your comprehensive 4-day event to stay ahead of cutting-edge developments, overcome delivery challenges, address translational bottlenecks, and create a bulletproof clinical development strategy, to propel the next wave of CNS gene therapies forward.
This summit will unite 200+ gene therapy and neurology leaders with a program designed to cater to everyone from Discovery through to Clinical Development; this is your only opportunity for a cover-to-cover discussion full of need-to-know and practical insights.
Now that the neurological gene therapy field has been given a renewed sense of direction, this is the opportunity for the community to capitalize on the start of a new wave of innovation and optimize the potential for gene therapies targeting neurological disorders.
To know more visit: https://ter.li/iblyl1

Extractables & Leachables Europe 2023
2023-11-06 - 2023-11-07 | Steinberger Airport Hotel, Stationsplein Zuid-West 951, 1117 CE Schiphol, Netherlands, 1117 CE, Netherlands
Join us at this year’s much-anticipated Extractables and Leachables Europe, taking place on 6-7 November 2023 in Amsterdam.
This year’s conference promises to once again provide you with everything you need to know about this ever-evolving sector. Extractables and leachables examination is continuously growing in importance. Given the current scrutiny paid by governing bodies including the FDA and MHRA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Whatever your level or position, and whether you’re from a CRO, pharmaceutical manufacturer, packaging specialist, instrument or equipment manufacturer, research or academic institution, chemical company or OEM – this conference has something for everyone.
With speakers from reputable companies like Element, GSK Vaccines, Aptar Pharma, Octapharma, Sartorius Stedim Biotech and numerous others, the agenda is bursting with insights, helping the conference be the most exceptional one to date.
Described by a previous attendee as ‘the place to be for the E&L community’, this is a mist-attend event for anyone working in the industry.
Find out more here: https://www.eandl-conference.com/extractables-and-leachables-europe
In addition to organising the renowned E&L events in Europe, US and China, Smithers also have a long history in providing E&L and medical device testing across the globe. Find out more at www.smithers.com.

PURIFY’23
2023-11-07 | ITC KOHENUR, HYDERABAD, INDIA
PURIFY – Chromatography Purification Conclave
PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups!
The pharmaceutical industry continues to dwell deeper into the growing possibilities for chromatography purification; the PURIFY conclaves touches upon diverse aspects of chromatography purification.
The attendees at PURIFY get exposed to a myriad of topics that could change the way they work…change the way they purify. New separation techniques and approaches, niche topics, deeper understanding of preparative and process chromatography and allied fields, and upcoming application areas that will provide quality substance to the discerning scientists. So, if you wish to get that additional gram, which is purer, in as less a time, with minimal resources…there will surely be something for you at PURIFY conclaves!
The annually occurring PURIFY Conclave is an initiative by Custage Marketing Solutions LLP, a Mumbai based company.
The PURIFY conclave is attended by analytical and research chemists, scientists with scale-up and process development knowledge, managers, group heads, natural product purification experts, experts from quality and manufacturing, academicians, policy makers, supply chain heads etc. of this pharmaceutical – APIs, peptides, proteins, oligonucleotides, chiral molecules, bio-pharmaceutical, fine chemicals, environmental studies, food and beverage, polymers, biotechnology, cosmetics and fragrance to understand the advancements in chromatography platforms.
So, the purification expert in you will surely get answers to the daily challenges faced for you in your laboratories. And what’s more, the knowledge comes to you from dignitaries who are institutions on their own in chromatography purification and related.
To know more visit: https://www.purifyconclaves.com/

7th Microbiome Movement – Human Nutrition Summit
2023-11-07 - 2023-11-09 | Westminster Hotel, 550 W Mt Pleasant Ave, Livingston, NJ, 07039, United States
The 7th Microbiome Movement – Human Nutrition Summit will unite 100+ human nutrition leaders this November in Livingston, NJ to optimize product development and consumer acceptance of microbiome-based food and nutritional products. Join the only industry led meeting dedicated to moving the needle on scientifically validated, microbiome modulating, nutritional product development.
From developing pre-, pro-, or post-biotics, functional food, microbiome modulating ingredients, to other interventions that provide microbial-mediated health benefits, this meeting offers unrivalled opportunities for those working in the microbiome human nutrition space.
Join us in Livingston, NJ, this November to hear invaluable insights from the likes of Bifidice, Danone, Holobiome, ADM, Immune Biome, and more!
View the full event guide here: https://ter.li/2ppxtz
Offering earlybird rates, exclusive group discounts and a brand-new, post-conference consumer focus day, now is the time to register. Don’t miss out, secure your place now: https://ter.li/8algsb

5th Annual Gene Therapy Analytical Development Summit 2023
2023-11-27 - 2023-11-30 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic.
In this context, the 5th Annual Gene Therapy Analytical Development is returning in 2023, uniting 400+ analytical experts to explore how the latest analytical methods are being developed and applied to guarantee the quality, consistency, safety, and efficacy of gene therapy products.
Join biopharma colleagues specializing in bioassays, molecular biology, physicochemical properties, quality, process development and regulation across 4 days of niche, expert presentations, and dedicated networking opportunities. This is your must-attend meeting to collaborate ideas, success and challenges to capitalize on the technological advances in analytical development to reach the ultimate goal of bringing safer, efficacious therapies to patients more quickly and effectively.
To know more visit: https://ter.li/qf50s3

7th Obesity & NASH Drug Development Summit
2023-11-27 - 2023-11-29 | The Westin Boston Seaport District, 425 Summer Street, Boston, MA, 02210, United States
Eli Lilly’s ‘triple G’ drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new record for the obesity field has been set and the time to get ahead of the curve is now. In parallel, we’re witnessing history being made with the world’s first approved NASH treatment potentially being right around the corner with Madrigal’s THR β-selective agonist, marking this year a pivotal time for the metabolic field to forever elevate the approach towards drug development and overcome regulatory barriers.
Reuniting metabolic experts to enable the assessment of the competitive landscape, the 7th Obesity & NASH Drug Development Summit is uniquely positioned to capture all the latest breakthroughs and research you need to join the race and commercialize your GLP-1 RAs, tri-agonists, dual agonists, tetra-specific drugs, glucocorticoid receptor modulators and more.
2023 is an exciting year due to the evolution in digital pathology, artificial intelligence, omics, multifunctional molecules, non-invasive biomarkers, target discovery and liver models, this is your timely meeting dedicated to bringing the metabolic community closer to navigate the route to even more approvals. However, as industry gets closer to successes, challenges remain.
Keen to overcome these discovery, regulatory, clinical, and commercial hurdles?
Join 160+ experts at the largest gathering of obesity and NASH industry drug developers from Eli Lilly, Novo Nordisk, Madrigal, Akero, Gilead, Pfizer, AstraZeneca, Gilead, Inventiva and many more to cultivate sustainable weight-loss drugs and navigate the route towards the first approval in NASH. Don’t miss your opportunity to hear from 42+ metabolic experts over 3 jam-packed days with all the latest end-to-end updates to advance your drug development.
To know more visit: https://bit.ly/465Aa3m

Cell Therapy for Autoimmune Disease Summit
2023-11-28 - 2023-11-30 | Sonesta Philadelphia Rittenhouse Square, 1800 Market Street, Philadelphia, PA, 19103, United States
Enter the inaugural Cell Therapy for Autoimmune Disease Summit, a pioneering platform singularly focused on uniting and empowering this community for the first time. Experts will delve into cutting-edge frontiers of pre-clinical, translational, and clinical advancements encompassing all cell-based therapies, including CAR-T, Treg, and MSC, with the shared objective of developing better therapies for patients with chronic autoimmune diseases.
Don’t miss out on your opportunity to network with 80+ key opinion leaders including Cabaletta Bio, Kyverna Therapeutics, AstraZeneca, Quell Therapeutics, Novartis, and more. Learn more – https://ter.li/6xwjrk

Donor Selection & Cell Source Summit 2023
2023-11-28 - 2023-11-30 | The Clift Royal Sonesta, 495 Geary Street, San Francisco, CA, 94102, United States
The Donor Selection & Cell Source Summit is your ultimate platform to explore the latest global regulatory requirements and differences on donor testing, understand the novel genome sequencing data being used to inform donor selection, and forge new partnerships to ease logistical coordination with donation sites to ensure exclusive availability of selected donor pools.
Join Senti Biosciences, Poseida Therapeutics, Caribou Bio, Allogene and more to advance your knowledge on donor selection, management and sustainability to ensure a consistent and reliable supply of cell source material required for clinical trials and beyond.
Download a copy of the event guide to view the 3-day jam-packed agenda, expert speaker faculty and exclusive pre-conference workshop day: https://ter.li/t81hko

4th Annual CRISPR 2.0 Congress 2023
2023-11-28 - 2023-11-30 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
CRISPR represents the next frontier in the cell and gene therapy landscape. Spearheaded by the first gene edited therapeutic awaiting FDA approval, a mounting wave of innovative technology developments and therapeutic applications are leading to a paradigm shift in our global healthcare systems.
To this end, the 4th Annual CRISPR 2.0 Congress is your definitive guide to showcasing the latest and greatest CRISPR tools being developed and applied in the therapeutic setting.
To know more visit: https://ter.li/rqwuyn

Advanced Purification for Complex Biologics Summit
2023-11-28 - 2023-11-30 | Sonesta Philadelphia Rittenhouse Square, 1800 Market Street, Philadelphia, PA, 19103, United States
The Advanced Purification for Complex Biologics Summit is the first and only standalone conference focused on purification for biologics and novel modalities bringing together purification, CMC and MSAT professionals to collaborate and remove purification bottlenecks to meet market delivery timelines.
This in-depth 3-day event will feature the latest breakthroughs and cutting-edge content in AI and digital learning tools to help you save time during downstream processing and boost efficiency.
This is your unique opportunity to meet 60+ purification and downstream processing experts including Sanofi, Takeda, Eli Lilly, AstraZeneca and Regeneron as they talk you through machine learning, predictive modelling, and consumables advancements to empower your process optimization, moving a step closer to 100% product purity.
To know more visit: https://ter.li/80pxjz

3rd ADC Target Selection Summit
2023-12-05 - 2023-12-07 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
The 3rd ADC Target Selection Summit (December 5-7 | Boston, MA). This is the ultimate cover-to-cover conference providing insights to help you optimize the pairing of target, antibody, and linker-payload and develop the next generation of clinically successful ADCs beyond HER2 and TROP2.
See the full program here.
As the number of new clinical ADC targets continues to increase, this year’s meeting will have a greater focus on identifying and validating novel targets, re-examining what makes a good target, and delving into the use of proteomics to ensure you get the first step of drug development right.
Here are some of the agenda highlights you cannot afford to miss:

Join Cancer Research Horizons to learn “Overcoming Hurdles in Validating Novel Targets for Clinically Applicable ADCs” and hear how an unbiased proteomics approach with patient samples was used to discover a clinically relevant ADC target for multiple myeloma
Hear from Ziel Bio on “Discovering Cell Surface Plectin: A Highly Promising Target for Multiple Solid Tumors” to understand how the hypothesized function of plectin highlights it as a good ADC target, and learn how ZB131 can selectively bind to CSP improving internalization and minimizing off-target effects
Gain insights from AstraZeneca on “A Case Study on Utilizing Hindsight Following Progression of an ADC With a HER2 Target Into the Clinic” highlighting the target selection process and reasons behind the choice of pursuing HER2, target and antibody considerations; and emphasizing challenges and successes in the use of this target for ADCs to help you prepare for your development.

Take a look at the full speaker faculty and session details.
Uniting 100+ of your peers working in biology, discovery and oncology research, this unique forum will provide you with an exclusive opportunity to learn and network with other ADC developers who are living and breathing targets all in one room.

3rd Applied Biocatalysis Summit
2023-12-05 - 2023-12-07 | The Study at University City, 20 S 33rd Street, Philadelphia, PA, 19104, United States
Enzyme Engineering Enabling Scalable Industrial Biotransformation for Sustainable API Production
In 2023, an era of advanced enzyme engineering technology is rapidly enabling the generation of game-changing enzymes for novel transformations. As witnessed for Merck’s Islatravir and BMS’ ERED/KRED biocatalytic cascade recognition, industries are fast transitioning towards biocatalysis to capitalize on more sustainable means of synthesis. The 3rd Applied Biocatalysis Summit is your must-attend meeting dedicated to accelerating enzyme discovery and reaction route development, through to scaling process chemistry for industrial applications.
With unmissable case studies from the likes of Merck, Amgen, Sanofi, Biogen, GSK, and Pfizer, this is the definitive forum to benchmark and learn with this forward-thinking community who reunite once more.
These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

Gaining valuable insights on chemoenzymatic catalysis research, combining heterogeneous and homogeneous catalysis and making valued functionality using biocatalysis, in water with Bruce Lipshutz, Professor of Chemistry, University of California, Santa Barbara
Learn how new technologies are adding efficiencies to biocatalysis’ adoption, including AI/ML approaches, improved screening for reaction prediction & new chemistry discoveries with Merck & Pfizer
Engage in dynamic panel discussions addressing how cross-departmental collaboration enable the faster assessment and introduction of enzymatic catalysed reactions as early as possible with AbbVie, Biogen & Neorocrine Biosciences

Don’t miss this opportunity to join trailblazers and accelerate enzyme discovery and engineering, discover carbon footprint-reducing reactions and refine your process scaling strategies.

Covalent Drug Discovery Summit
2023-12-12 - 2023-12-14 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Bringing the covalency field under one roof for the first time, the inaugural Covalent Drug Discovery Summit comes to Boston this December – gathering 80+ covalent drug specialists from the likes of Amgen, Revolution Medicines, Novartis, Totus Medicines, Covant Therapeutics and more.
This is a unique opportunity to network with an audience of CXOs, VPs, Directors and Heads of Discovery, Medicinal and Biological Chemistry focused on covalent drug discovery.
Hear from 20+ industry leaders across three days of carefully curated content, engage in dedicated networking time with the field, ask your burning questions to our expert speakers at the end of each presentation, and dive deep into two interactive workshops on toxicity and safety concerns and the future of covalency.
Download your copy of the program here to find out more: https://ter.li/z6hwj6

6th RNA-Targeted Drug Discovery & Development Summit
2023-12-12 - 2023-12-14 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
200+ Attendees | 33+ World-Class Speakers | 23+ Data Driven Case Studies
Returning to Boston this December for its 6th year, the RNA-Targeted Drug Discovery & Development Summit is the only industry-dedicated forum solely focused on small molecules targeting RNA, with a core focus on improving selectivity and specificity to enable safe and effective drugs into the clinic.
View the program here: https://ter.li/xq2eye
2023 has seen advances in artificial intelligence, screening tools and progression into the clinic, coupled with numerous strategic collaborations and investments into early discovery.
Bringing together 33+ experts presenting the latest data and case studies straight from the lab, alongside senior decision makers discussing key breakthroughs and strategy, this year’s meeting is a must-attend if you are looking to turbocharge discovery and development of small molecules targeting RNA.
Register here: https://ter.li/r67ejq

Health Economics & Outcomes Research Summit
2023-12-12 - 2023-12-14 | Wyndham Philadelphia Historic District, 400 Arch Street, Philadelphia, PA, 19106, United States
The Health Economics & Outcomes Research Summit is a focused intimate gathering of HEOR professionals, moving past basic introductions to advanced tactical and strategic conversations best leveraging innovative methods to demonstrate the value proposition of new drugs to secure formulary and market access.
Hear cutting-edge case studies into evidence generation, modeling and real-world evidence across oncology, neurology, cardiovascular, rare diseases, and beyond. Explore how leading pharma and pioneering biotechs are navigating this changing landscape including:

Adapting value assessments for evolving reimbursement requirements
Adjusting to price control mechanisms implemented by the Inflation Reduction Act
Leveraging advances AI to revolutionize data-driven decision-making

Join this gathering of HEOR experts and gain strategic and commercial market intelligence by exploring how thought leaders are redefining a robust strategy to demonstrate the clinical effectiveness, safety, and cost-effectiveness of new drugs, don’t miss out on your opportunity to fortify a resilient decision-making framework.
To know more visit: https://bit.ly/3PTp5M4

8th Oncolytic Virotherapy Summit 2023
2023-12-12 - 2023-12-14 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Following recent struggles in the industry, the leading annual 8th Oncolytic Virotherapy Summit returns to Boston, MA in December (12-14), as the industry’s definitive, and most comprehensive forum. Bringing you 29+ world-class speakers, 10+ hours of networking, 2-panel discussions, 1 pre-conference focus day & more. This event will be showcasing brand-new pivotal data to ensure a pathway of success for regulatory approval of OV drugs.
3 days of carefully curated sessions will gather 100+ OV trailblazers across sessions spanning Early Discovery, Translation, Clinical Development, Chemistry, Manufacturing & Controls (CMC), and Regulations to overcome the industry’s largest and critical bottlenecks. Here is just a snapshot of our world-class speaker line-up who will be showcasing their expertise and critical updates:

Richard Dambra, Scientist, Viral Platforms, Boehringer Ingelheim
Francesca Barone, CSO, Candel Therapeutics
Michael Franti, Director, Viral Platform Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim
Paul Hallenbeck, Chief Scientific Officer, Seneca Therapeutics
Talia Biran, President Clinical Development Operations, Oncolys

This year’s edition brings highly promising content such as the exclusive Innovation Showcase, a whole day dedicated to Clinical Design & Manufacturing Strategies and a must-attend Investor Panel from experts in Biopharma.
As the only and longest established end-to-end OV-focused conference, this is a crucial date in the industry calendar you cannot afford to miss.
To know more visit: https://ter.li/1ag3m6

Gene Therapy Process Development Summit
2023-12-13 - 2023-12-14 | Le Meridien Philadelphia, 1421 Arch Street, Philadelphia, PA, 19102, United States
The inaugural Gene Therapy Process Development Summit is a must-attend to discover the latest insights to bridge the gap between R&D and process development, ensuring that high-quality gene therapies are manufactured repeatably, at scale, and in a cost-effective manner.
Join us in Philadelphia to discover and learn the latest insights through case study presentations, informative panel discussions, and deep-dive workshops from Ultragenyx, REGENXBIO, Janssen, Amgen, Astellas Gene Therapies, and many more!
Whether you are looking to improve your platform processes or shorten development timelines this summit will be a unique opportunity to meet and network with peers to discuss successes and challenges in your process development journeys.
Join your peers to:

Learn how to achieve the ideal complex size with Meira GTx by using automation and process analytical tools to optimize transient transfection leading to enhanced efficiency, time saving and scale-up insights
Deep dive into enhancing the Pinnacle PCL Platform 2000L batch process with Ultragenyx to increase yield, improve product quality and reduce time-to-clinic
Examine case study results with Astellas Gene Therapies and explore the optimization techniques to cut costs and streamline tech transfer and scale-up times
Explore the design principles for creating robust AAV producer cell lines to yield a stable and consistent AAV production to optimize AAV vector generation to improve your platform processes with Lacerta and REGENXBIO
Unpick the ever-changing, complex regulations surrounding the world of gene therapy in a detailed workshop that doubles down on development strategies that are adaptable to the challenges by gene therapy to prevent regulatory roadblocks when trying to get drugs to clinic

Download the full agenda here to see our full speaker faculty, 2-day agenda and audience breakdown: https://ter.li/nxp0nz

Pre-Filled Syringes and Injectable Drug Devices Europe
2024-01-09 - 2024-01-11 | LEONARDO ROYAL HOTEL LONDON TOWER BRIDGE, 45 Prescot Street, London, E1 8GP, United Kingdom
SAE Media Group’s 16th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January 2024 to unite leaders from the industry and bring you the latest advances in the combination product drug delivery space.

Year on year, the field of injectable drug delivery has witnessed remarkable progress, marked by advancements in device technology, including smart devices and those designed for large volume drug administration. There has been a shift towards enhancing the patient experience through innovative device design. Moreover, the industry is now moving towards a circular approach for environmental sustainability, incorporating it into device manufacturing and design, as well as device usage. The upcoming conference aims to tackle pressing industry challenges by exploring them through real-world case studies and valuable insights while also considering opportunities for the future.
As part of SAE’s leading Injectable Drug Delivery Series, the 3-day event will comprise of a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below addressing the industry’s hottest topics:

Device Innovations for Large Volume and Highly Viscous Drug Delivery
Sustainability by Design and Material Selection
Primary Packaging Development
Digital Integration for Connected Devices

This event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in January 2024!
Benefits of attending:

Engage with pharma, biotech and device developers on the latest trends within the pre-filled syringe and injectable device market
Hear about new technological advances in the delivery of large volume drugs and novel drug products
Understand the latest regulatory requirements from experts surrounding medical devices and digital health
Gain insight into how big pharma is incorporating sustainable approaches into drug device design
Delve into the growing potential of digital health to improve patient experience and treatment

Explore key considerations for material components for the development of primary packaging
To know more visit: www.pre-filled-syringes.com/PharmaJournalist-WL

Gene Therapy Regulatory Affairs Summit
2024-01-23 - 2024-01-25 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their heels for approval, investment is pouring into developing gene therapies and the role of regulatory affairs has never been more important.
As the first ever regulatory affairs forum wholly dedicated to gene therapy, this meeting uniquely unites regulatory bodies and the leading regulatory personnel across big pharma and innovative biotech to discuss the hottest topics, identify industry bottlenecks and offer actionable insights.
Join 80+ industry leaders from 4D Molecular Therapeutics, Advanced Cell & Gene Therapy, Adverum Biotechnologies, Astrazeneca, Bridge Bio, Health Canada, Omega Therapeutics, Opus Genetics, Regeneron Pharmaceuticals, Sangamo Therapeutics, Solid Biosciences, Spark Therapeutics, Ultragenyx Pharmaceutical, and more…
By attending this summit, you will get a chance to:

Understand the nuanced differences and the route to harmonization in global regulation across the EMA, MHRA, FDA & Health Canada
Hone your regulatory intelligence, understand how to use biomarkers as surrogate endpoints and perfect clinical trial strategy for regulatory success
Explore the next steps for specific technologies beyond AAV and novel regulatory route
Hear from the regulators in the Health Canada and the FDA to have your queries clarified

Overcome your CMC hurdles to prove the efficacy, purity & comparability of your compound to avoid later setbacks in poor manufacturing preparation
Don’t miss out on this unrivalled opportunity to inform your trial design, perfect your CMC approach and supercharge your global submission strategy for regulatory success.
Download the full agenda here to see our full speaker faculty, 3-day agenda and audience breakdown: https://ter.li/sgkcr9

3rd mRNA-Based Therapeutics Summit Europe
2024-01-23 - 2024-01-25 | Mecure Hotel MOA Berin, Stephanstraße 41, Berlin, 10559, Germany
250+ mRNA Specialists | 40+ World-Class Speakers | 2 Streams of Content
The 3rd mRNA-Based Therapeutics Summit Europe returns to Berlin this 23rd-25th January to unite European biopharma, to hear from the likes of BioNTech, CureVac, Moderna, Pfizer, Ethris, Sanofi, and regulatory insights for the MHRA and EMA.
Download the full brochure here: https://ter.li/1329up
This is your opportunity to hear the hottest content of the mRNA world, deep diving into two content tracks on Translational Development and CMC, a pre-conference Focus Day on AI RNA Design & Delivery, and three immersive pre-conference workshops.
Join in January to understand the roadmap towards clinical success and regulatory approval, and deliver the promise of better mRNA medicines to patients faster.
Book your place here: https://ter.li/qu2h8f

2nd Next Generation Ophthalmic Drug Delivery Summit
2024-01-30 - 2024-02-01 | The Marker San Francisco, 501 Geary St, San Francisco, CA, 94102, United States
The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers, biochemists, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration.
Join 23+ expert speakers from the likes of AbbVie, Boehringer Ingelheim, Bayer, Genentech, Janssen, Novartis, and Clearside Biomedical at the only industry-dedicated event focusing on overcoming key translational challenges of developing and implementing novel delivery technology as they progress their ophthalmic pipelines to the clinic.
To know more visit: https://ter.li/o3pq3n

8th Microbiome Movement - Drug Development Summit Europe
2024-01-30 - 2024-02-01 | Hotel Barceló Sants, Pl. dels Països Catalans, s/n, 08014, Barcelona, 08014, Spain
As Europe’s premiere microbiome conference tightly focused on the development of microbiome-based therapeutics, this is your prime opportunity to expand your microbiome-based drug development capabilities and business potential as we aim to deliver clinical results and ensure therapeutic microbiome approval in Europe.
No matter what stage of development you’re focusing on, this is your one-stop shop for microbiome-based drug development from early discovery to late-phase manufacturing!
What’s New for 2024:

Highlighting early-stage organisations and their novel technologies in our brand-new technology showcase where we welcome Centre for Genomic Regulation, Recolony and Synflora to give quick fire presentations to showcase their work.
Discover our new enabling technologies track to learn more about the exciting artificial intelligence, integrated -omics analysis and improved manufacturing capabilities among the other technologies that are accelerating microbiome-based drug development.
Strengthen your regulatory understanding and enhance decision-making by uncovering global regulations to address updated SoHo frameworks, explore considerations for engineered microbes and consolidate agencies interactions

To know more visit: https://ter.li/zi3xwf
